NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

中國的Voriconazole市場分析(2021年∼2025年)

Investigation Report on China's Voriconazole Market 2021-2025

出版商 China Research and Intelligence 商品編碼 1008263
出版日期 內容資訊 英文 50 Pages
商品交期: 最快1-2個工作天內
價格
中國的Voriconazole市場分析(2021年∼2025年) Investigation Report on China's Voriconazole Market 2021-2025
出版日期: 2021年05月28日內容資訊: 英文 50 Pages
簡介

Voriconazole,是可能威脅生命的真菌感染疾病的治療所使用的真菌症治療藥,由Pfizer開發。中國2004年Voriconazole獲批。中國製造Voriconazole的企業2020年時佔11家公司,其中Pfizer有最大的佔有率。

中國的Voriconazole的銷售額從2016年到2019年順利增加。可是,受到新型冠狀病毒感染疾病(COVID-19)的影響,銷售額從2019年的18億8,800萬人民幣到2020年為15億300萬人民幣,減少了20.41%。中國市場從2016年到2020年的年複合成長率為2.68%。

本報告提供中國的Voriconazole市場相關調查,產品概要,新型冠狀病毒感染疾病(COVID-19)的影響,中國整體及各地區的銷售趨勢,製藥企業的市場佔有率,銷售額及銷售額數,價格趨勢,市場預測,市場成長要素,市場機會,課題等彙整資料。

目錄

第1章 Voriconazole概要

  • Voriconazole的適應症
  • 中國的Voriconazole的開發
  • 中國的Voriconazole的政府核准
  • 新型冠狀病毒感染疾病(COVID-19)對銷售的影響

第2章 中國的Voriconazole的銷售趨勢(2016年∼2020年)

  • Voriconazole的銷售額
    • 銷售額:全體
    • 銷售額:各地區
  • Voriconazole的銷售額數
    • 銷售額數:全體
    • 銷售額數:各地區
  • Voriconazole的銷售趨勢:各劑型
    • 口服懸浮液
    • 注射劑
    • 平板電腦
    • 膠囊

第3章 中國的主要Voriconazole製造企業(2016年∼2020年)

  • 主要企業的市場佔有率
    • 銷售額
    • 銷售額數
  • Pfizer Europe MA EEIG
    • 企業概要
    • 中國的VFEND的銷售額
  • Pfizer Ltd
    • 企業概要
    • 中國的VFEND的銷售額
  • Sichuan Meidakang Pharmaceutical Co., Ltd.
    • 企業概要
    • 中國的HUIDELIKANG的銷售額
  • Yangtze River Pharmaceutical Group Nanjing Hailing Pharmaceutical Co., Ltd.
    • 企業概要
    • 中國的FURUI的銷售額
  • Zhuhai Ebang Pharmaceutical Co., Ltd.
    • 企業概要
    • 中國的HUIBANGLING的銷售額

第4章 中國的Voriconazole的價格(2020年∼2021年)

  • Pfizer Europe MA EEIG (VFEND)
  • Pfizer Ltd (VFEND)
  • Sichuan Meidakang Pharmaceutical Co., Ltd. (HUIDELIKANG)
  • Yangtze River Pharmaceutical Group Nanjing Hailing Pharmaceutical Co., Ltd. (FURUI)
  • Zhuhai Ebang Pharmaceutical Co., Ltd.(HUIBANGLING)

第5章 中國的Voriconazole市場預測(2021年∼2025年)

  • 市場發展的影響要素
    • 新型冠狀病毒感染疾病(COVID-19)的影響
    • 市場成長要素和機會
    • 市場威脅與課題
  • 市場規模的預測
  • 市場趨勢的預測
目錄
Product Code: 2105498

Voriconazole is used to treat progressive, potentially life-threatening fungal infections. Its product was developed by Pfizer. It was approved in China in 2004. By 2020, there are 11 manufacturers of Voriconazole in the Chinese market, of which Pfizer has the largest market share.

According to CRI analysis, the sales of Voriconazole have grown steadily from 2016 to 2019. In 2020, its sales fell by 20.41%, from CNY1.888 billion in 2019 to CNY1.503 billion in 2020. The main reason is that the Covid-19 epidemic has affected the hospital's overall diagnosis and treatment business, resulting in a decline in its sales. The CAGR of Voriconazole in the Chinese market from 2016 to 2020 is 2.68%.

According to CRI analysis, with the effective alleviation of the Covid-19 epidemic from 2021 to 2025, the sales of Voriconazole will have a restorative growth. In addition, there are 9 companies that have applied to enter the Chinese Voriconazole market in 2020. The price of Voriconazole will decline and the sales and sales volume have the potential for growth with the addition of new manufacturers. In addition, Voriconazole is used for various fungal infections and the number of specific indications is likely to increase, so its sales volume and sales still have the potential for increase.

Topics Covered:

  • The impact of COVID-19 on China's Voriconazole market
  • Sales value of China's Voriconazole 2016-2020
  • Competitive landscape of China's Voriconazole market
  • Prices of Voriconazole in China
  • Prices of Voriconazole in China by regions and manufacturers
  • Analysis of factors affecting the development of China's Voriconazole market
  • Prospect of China's Voriconazole market from 2021 to 2025

Table of Contents

1 Relevant Concept of Voriconazole

  • 1.1 Indications for Voriconazole
  • 1.2 Development of Voriconazole in China
  • 1.3 Governmental Approval of Voriconazole in China
  • 1.4 The Impact of COVID-19 on Voriconazole sales in China

2 Sales of Voriconazole in China, 2016-2020

  • 2.1 Sales Value of Voriconazole
    • 2.1.1 Overall Sales Value
    • 2.1.2 Sales Value by Regions
  • 2.2 Sales Volume of Voriconazole
    • 2.2.1 Overall Sales Volume
    • 2.2.2 Sales Volume by Regions
  • 2.3 Sales of Voriconazole by Dosage Form in China, 2016-2020
    • 2.3.1 Oral suspension
    • 2.3.2 Injection
    • 2.3.3 Tablets
    • 2.3.4 Capsules

3 Analysis of Major Voriconazole Manufacturers in China, 2016-2020

  • 3.1 Analysis of Market Share of Major Voriconazole Manufacturers
    • 3.1.1 Investigation on Market Share by Sales Value
    • 3.1.2 Investigation on Market Share by Sales volume
  • 3.2 Pfizer Europe MA EEIG
    • 3.2.1 Enterprise Profile
    • 3.2.2 Sales of VFEND (Pfizer Europe MA EEIG's Voriconazole) in China
  • 3.3 Pfizer Ltd
    • 3.3.1 Enterprise Profile
    • 3.3.2 Sales of VFEND (Pfizer Ltd's Voriconazole) in China
  • 3.4 Sichuan Meidakang Pharmaceutical Co., Ltd.
    • 3.4.1 Enterprise Profile
    • 3.4.2 Sales of Huidelikang (Sichuan Meidakang Pharmaceutical Co.,Ltd.'s Voriconazole) in China
  • 3.5 Yangtze River Pharmaceutical Group Nanjing Hailing Pharmaceutical Co., Ltd.
    • 3.5.1 Enterprise Profile
    • 3.5.2 Sales of Furui (Yangtze River Pharmaceutical Group Nanjing Hailing Pharmaceutical Co., Ltd.'s Voriconazole) in China
  • 3.6 Zhuhai Ebang Pharmaceutical Co., Ltd.
    • 3.6.1 Enterprise Profile
    • 3.6.2 Sales of Huibangling (Zhuhai Ebang Pharmaceutical Co.,Ltd.'s Voriconazole) in China

4 Prices of Voriconazole for Different Manufacturers in China, 2020-2021

  • 4.1 Pfizer Europe MA EEIG (VFEND)
  • 4.2 Pfizer Ltd (VFEND)
  • 4.3 Sichuan Meidakang Pharmaceutical Co., Ltd. (Huidelikang)
  • 4.4 Yangtze River Pharmaceutical Group Nanjing Hailing Pharmaceutical Co., Ltd. (Furui)
  • 4.5 Zhuhai Ebang Pharmaceutical Co., Ltd.(Huibangling)

5 Prospect of Chinese Voriconazole Market, 2021-2025

  • 5.1 Influential Factors of Chinese Voriconazole Market Development
    • 5.1.1 The Impact of COVID-19 on Chinese Voriconazole Market
    • 5.1.2 Market Drivers and Opportunities
    • 5.1.3 Market Threats and Challenges
  • 5.2 Forecast on Market Size
  • 5.3 Forecast on Market Trend

List of Charts

  • Chart Patent Information About Voriconazole Oral Suspension Registration in China
  • Chart Patent Information About Voriconazole Injection Registration in China
  • Chart Patent Information About Voriconazole Tablets Registration in China
  • Chart Patent Information About Voriconazole Capsules Registration in China
  • Chart Sales Value of Voriconazole Oral Suspension over the World
  • Chart Sales Value of Voriconazole Injection over the World
  • Chart Sales Value of Voriconazole Tablets over the World
  • Chart Sales Value of Voriconazole Capsules over the World
  • Chart Sales Value of Voriconazole Oral Suspension in China, 2016-2020
  • Chart Sales Value of Voriconazole Injection in China, 2016-2020
  • Chart Sales Value of Voriconazole Tablets in China, 2016-2020
  • Chart Sales Value of Voriconazole Capsules in China, 2016-2020
  • Chart Sales Value of Voriconazole Oral Suspension in China by Regions, 2016-2020
  • Chart Sales Value of Voriconazole Injection in China by Regions, 2016-2020
  • Chart Sales Value of Voriconazole Tablets in China by Regions, 2016-2020
  • Chart Sales Value of Voriconazole Capsules in China by Regions, 2016-2020
  • Chart Sales Volume of Voriconazole Oral Suspension in China, 2016-2020
  • Chart Sales Volume of Voriconazole Injection in China, 2016-2020
  • Chart Sales Volume of Voriconazole Tablets in China, 2016-2020
  • Chart Sales Volume of Voriconazole Capsules in China, 2016-2020
  • Chart Sales Volume of Voriconazole Oral Suspension in China by Regions, 2016-2020
  • Chart Sales Volume of Voriconazole Injection in China by Regions, 2016-2020
  • Chart Sales Volume of Voriconazole Tablets in China by Regions, 2016-2020
  • Chart Sales Volume of Voriconazole Capsules in China by Regions, 2016-2020
  • Chart Market Share by Sales Value of Top Voriconazole Oral Suspension Manufacturers in China, 2016-2020
  • Chart Market Share by Sales Value of Top Voriconazole Injection Manufacturers in China, 2016-2020
  • Chart Market Share by Sales Value of Top Voriconazole Tablets Manufacturers in China, 2016-2020
  • Chart Market Share by Sales Value of Top Voriconazole Capsules Manufacturers in China, 2016-2020
  • Chart Sales Value and Volume of VFEND (Pfizer Europe MA EEIG's Voriconazole) in China, 2016-2020
  • Chart Sales Value and Volume of VFEND (Pfizer Ltd's Voriconazole) in China, 2016-2020
  • Chart Sales Value and Volume of Huidelikang in China, 2016-2020
  • Chart Sales Value and Volume of Furui in China, 2016-2020
  • Chart Sales Value and Volume of Huibangling in China, 2016-2020
  • Chart Referential Prices of VFEND (Pfizer Europe MA EEIG's Voriconazole) in China by Regions, 2020-2021
  • Chart Referential Prices of VFEND (Pfizer Ltd's Voriconazole) in China by Regions, 2020-2021
  • Chart Referential Prices of Huidelikang in China by Regions, 2020-2021
  • Chart Referential Prices of Furui in China by Regions, 2020-2021
  • Chart Referential Prices of Huibangling in China by Regions, 2020-2021
  • Chart Forecast on Sales Value of Voriconazole Oral Suspension in China, 2021-2025
  • Chart Forecast on Sales Value of Voriconazole Injection in China, 2021-2025
  • Chart Forecast on Sales Value of Voriconazole Tablets in China, 2021-2025
  • Chart Forecast on Sales Value of Voriconazole Capsules in China, 2021-2025
  • Chart Forecast on Sales Volume of Voriconazole Oral Suspension in China, 2021-2025
  • Chart Forecast on Sales Volume of Voriconazole Injection in China, 2021-2025
  • Chart Forecast on Sales Volume of Voriconazole Tablets in China, 2021-2025
  • Chart Forecast on Sales Volume of Voriconazole Capsules in China, 2021-2025